CHECHE GROUP INC (CCG)

KYG207071088 - Common Stock

0.76  -0.03 (-3.8%)

Fundamental Rating

2

CCG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 141 industry peers in the Insurance industry. The financial health of CCG is average, but there are quite some concerns on its profitability. CCG has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year CCG has reported negative net income.
CCG had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCG reported negative net income in multiple years.
CCG had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -103.11%, CCG is doing worse than 98.57% of the companies in the same industry.
CCG has a worse Return On Equity (-243.73%) than 97.14% of its industry peers.
Industry RankSector Rank
ROA -103.11%
ROE -243.73%
ROIC N/A
ROA(3y)-28.71%
ROA(5y)N/A
ROE(3y)-75.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CCG has a Gross Margin of 4.25%. This is amongst the best in the industry. CCG outperforms 87.86% of its industry peers.
CCG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

CCG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CCG has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CCG has a worse debt to assets ratio.

2.2 Solvency

CCG has an Altman-Z score of 0.66. This is a bad value and indicates that CCG is not financially healthy and even has some risk of bankruptcy.
CCG's Altman-Z score of 0.66 is fine compared to the rest of the industry. CCG outperforms 77.86% of its industry peers.
CCG has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
CCG has a better Debt to Equity ratio (0.05) than 86.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACCN/A
WACC7.46%

2.3 Liquidity

A Current Ratio of 1.56 indicates that CCG should not have too much problems paying its short term obligations.
The Current ratio of CCG (1.56) is better than 90.71% of its industry peers.
CCG has a Quick Ratio of 1.56. This is a normal value and indicates that CCG is financially healthy and should not expect problems in meeting its short term obligations.
CCG has a Quick ratio of 1.56. This is amongst the best in the industry. CCG outperforms 90.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56

3

3. Growth

3.1 Past

The earnings per share for CCG have decreased strongly by -4834.74% in the last year.
EPS 1Y (TTM)-4834.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-349.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CCG will show a very strong growth in Earnings Per Share. The EPS will grow by 27.50% on average per year.
CCG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 104.80% yearly.
EPS Next Y58.28%
EPS Next 2Y33.96%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year664.15%
Revenue Next 2Y180.2%
Revenue Next 3Y104.8%
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CCG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CCG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CCG's earnings are expected to grow with 27.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.96%
EPS Next 3Y27.5%

0

5. Dividend

5.1 Amount

CCG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHECHE GROUP INC

NASDAQ:CCG (12/19/2024, 10:22:13 AM)

0.76

-0.03 (-3.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-26 2024-11-26/bmo
Earnings (Next)N/A N/A
Inst Owners0.53%
Inst Owner Change2.03%
Ins Owners1.15%
Ins Owner Change0%
Market Cap59.17M
Analysts80
Price Target3.06 (302.63%)
Short Float %0.15%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 1.14
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-1.67
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS5.82
BVpS0.67
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.11%
ROE -243.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.25%
FCFM N/A
ROA(3y)-28.71%
ROA(5y)N/A
ROE(3y)-75.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover3.69
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.43%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.66
F-Score4
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4834.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-349.84%
EPS Next Y58.28%
EPS Next 2Y33.96%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year664.15%
Revenue Next 2Y180.2%
Revenue Next 3Y104.8%
Revenue Next 5YN/A
EBIT growth 1Y-7662.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-170.13%
EBIT Next 3Y36.43%
EBIT Next 5YN/A
FCF growth 1Y-4895.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4795.82%
OCF growth 3YN/A
OCF growth 5YN/A